List view / Grid view
Conclusion of ‘landmark’ deal significantly enhances trade, investment and supply…
Conclusion of ‘landmark’ deal significantly enhances trade, investment and supply chains, notably granting beneficial tariff reductions for the pharma industry.
European pharma industry acknowledges the progress made, particularly with partial…
European pharma industry acknowledges the progress made, particularly with partial tariff reductions, but said further provisions could have been achieved.
Establishes Resource for AI Science in Europe and eyes frontier…
Establishes Resource for AI Science in Europe and eyes frontier AI models and autonomous agentic AI for pharma.
Marking the first step in the negotiation process, this deal…
Marking the first step in the negotiation process, this deal establishes key parameters of the final political agreement on trade and tariffs between the EU and US.
Digitalisation, R&D and AMR were highlighted as key areas of…
Digitalisation, R&D and AMR were highlighted as key areas of focus to support European competitiveness up to the end of the decade, as set out in new Political Guidelines for Europe.
BioNTech will evaluate mRNA vaccine manufacturing facilities in Rwanda and…
BioNTech will evaluate mRNA vaccine manufacturing facilities in Rwanda and Senegal to support vaccine supply in African states.
The addition of €500 million to the EU’s existing COVAX…
The addition of €500 million to the EU’s existing COVAX Facility pledge was announced at the G7 summit virtual leaders' meeting.
After manufacturing delays, AstraZeneca will now provide the EU with…
After manufacturing delays, AstraZeneca will now provide the EU with the 40 million COVID-19 vaccine doses it originally agreed to supply.
The European Investment Bank (EIB), in partnership with the European…
The European Investment Bank (EIB), in partnership with the European Commission (EC), have pledged an additional €4.9 billion for use in the global coronavirus response funds.
European Pharmaceutical Review brings you the latest updates from regulatory…
European Pharmaceutical Review brings you the latest updates from regulatory bodies across the globe in response to the COVID-19 coronavirus.
The European Commision (EC) has announced €80 million of support…
The European Commision (EC) has announced €80 million of support to aid in the R&D and production of a COVID-19 coronavirus vaccine.
